Marcum Wealth’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$232K Sell
997
-18
-2% -$4.37K 0.02% 340
2024
Q4
$233K Sell
1,015
-24
-2% -$5.51K 0.02% 333
2024
Q3
$232K Buy
1,039
+30
+3% +$6.59K 0.02% 333
2024
Q2
$205K Sell
1,009
-8
-0.8% -$1.63K 0.02% 334
2024
Q1
$222K Buy
1,017
+13
+1% +$2.86K 0.02% 323
2023
Q4
$228K Sell
1,004
-86
-8% -$18.1K 0.02% 310
2023
Q3
$219K Sell
1,090
-98
-8% -$20.7K 0.03% 302
2023
Q2
$246K Buy
1,188
+57
+5% +$11.1K 0.03% 283
2023
Q1
$223K Buy
+1,131
New +$233K 0.03% 300
2022
Q2
Sell
-916
Closed -$208K 404
2022
Q1
$208K Buy
+916
New +$215K 0.03% 315

Other funds holding LH

Marcum Wealth's LH Position: Q1 2025 in Review

Marcum Wealth reduced its Labcorp (LH) stake by 1.8% in Q1 2025, selling an estimated $4.37K and leaving 997 shares worth $232K. The position accounts for 0.02% of the portfolio, ranked #340.

Marcum Wealth first reported a position in LH in Q1 2022 and has held it in 10 quarters since. The position peaked at $246K in Q2 2023. 973 funds tracked by Wall St. Rank hold LH as of Q1 2025.

  • Marcum Wealth held 997 shares of Labcorp worth $232K as of Q1 2025.
  • Marcum Wealth sold 18 Labcorp shares in Q1 2025, an estimated $4.37K.
  • Labcorp made up 0.02% of Marcum Wealth's portfolio in Q1 2025, its #340 holding.
  • Marcum Wealth first reported a position in Labcorp in Q1 2022 and has held it in 10 quarters since.
  • Marcum Wealth's Labcorp position peaked at $246K in Q2 2023.
  • 973 funds tracked by Wall St. Rank held Labcorp as of Q1 2025.

Based on Marcum Wealth's 13F filing for Q1 2025, filed 2 Apr 2025.